Chowning is a composer, musician and professor that had a seismic impact on both the development of music technology and the ...

HeartBeam Recently Received US Food and Drug Administration (FDA) Clearance for First-Ever Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment Pivotal Milestone Unlocks Multiple Key ...

Modern music production demands instruments that inspire creativity while delivering professional-quality sound. Whether you're crafting electronic beats, scoring film, or layering textures beneath a ...

HeartBeam Inc. has obtained FDA 510(k) clearance for its 12-lead ECG synthesis software for arrhythmia assessment following a successful appeal, enabling remote cardiac monitoring with a planned U.S.

HeartBeam, Inc. (BEAT) (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...

HeartBeam, Inc.’s (NASDAQ: BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro. On Wednesday, ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...

FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers Clinical-Grade Insights Directly to Patients ...

A screenshot from a video demonstrating how to use the HeartBeam ECG device. HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...

HeartBeam Inc. is pursuing multiple regulatory paths after receiving a Not Substantially Equivalent decision from the FDA for its 12-lead ECG Synthesis Software, with the company indicating recent ...

Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints Company believes that labeling modifications can ...